{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T16:04:08Z","timestamp":1780589048647,"version":"3.54.1"},"reference-count":21,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Actas Urol\u00f3gicas Espa\u00f1olas (English Edition)"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.acuroe.2026.501904","type":"journal-article","created":{"date-parts":[[2026,1,5]],"date-time":"2026-01-05T16:15:44Z","timestamp":1767629744000},"page":"501904","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["The use of presurgical urine cytology improves patient selection for a single instillation of MMC"],"prefix":"10.1016","volume":"50","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5350-7214","authenticated-orcid":false,"given":"C.","family":"G\u00f3mez del Ca\u00f1izo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.","family":"Fern\u00e1ndez S\u00e1nchez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I.","family":"Gonz\u00e1lez Ginel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Hern\u00e1ndez Arroyo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Mart\u00edn-Arriscado Arroba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"de la Calle Moreno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Rodr\u00edguez Antol\u00edn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Guerrero Ramos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.acuroe.2026.501904_bib0005","series-title":"Data visualization tools for exploring the global cancer burden in 2022","year":"2023"},{"key":"10.1016\/j.acuroe.2026.501904_bib0010","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.eururo.2021.08.010","article-title":"European Association of Urology Guidelines on Non\u2013muscle-invasive Bladder Cancer (Ta, T1, and Carcinoma in Situ)","volume":"81","author":"Babjuk","year":"2022","journal-title":"Eur Urol"},{"key":"10.1016\/j.acuroe.2026.501904_bib0015","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1007\/s13193-016-0586-1","article-title":"Current concepts in the management of muscle invasive bladder cancer","volume":"8","author":"Krishna","year":"2017","journal-title":"Indian J Surg Oncol"},{"key":"10.1016\/j.acuroe.2026.501904_bib0020","first-page":"15","article-title":"Epidemiology of bladder cancer","volume":"8","author":"Saginala","year":"2020","journal-title":"Med Sci"},{"key":"10.1016\/j.acuroe.2026.501904_bib0025","doi-asserted-by":"crossref","first-page":"e87","DOI":"10.1016\/j.clgc.2013.07.007","article-title":"Significance of positive urine cytology on progression and cancer-specific mortality of non\u2013muscle-invasive bladder cancer","volume":"12","author":"Koga","year":"2014","journal-title":"Clin Genitourin Cancer"},{"key":"10.1016\/j.acuroe.2026.501904_bib0030","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1002\/dc.24531","article-title":"The predictive value of positive and suspicious urine cytology: are they different?","volume":"48","author":"Kuan","year":"2020","journal-title":"Diagn Cytopathol"},{"key":"10.1016\/j.acuroe.2026.501904_bib0035","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1002\/cncy.21764","article-title":"The positive predictive value of \"suspicious for high-grade urothelial carcinoma\" in urinary tract cytology specimens: a single-institution study of 665 cases","volume":"124","author":"Joudi","year":"2016","journal-title":"Cancer Cytopathol"},{"key":"10.1016\/j.acuroe.2026.501904_bib0040","doi-asserted-by":"crossref","first-page":"e15","DOI":"10.1016\/j.urolonc.2024.03.014","article-title":"Voided urine cytology is a useful tool predicting non-muscle-invasive bladder cancer risk before surgery","volume":"42","author":"G\u00f3mez Del Ca\u00f1izo","year":"2024","journal-title":"Urol Oncol"},{"issue":"6 Pt 1","key":"10.1016\/j.acuroe.2026.501904_bib0045","doi-asserted-by":"crossref","first-page":"2186","DOI":"10.1097\/01.ju.0000125486.92260.b2","article-title":"A single immediate postoperative instillation of chemotherapy decreases the risk of recurrence in patients with stage Ta T1 bladder cancer: a meta-analysis of published results of randomized clinical trials","volume":"171","author":"Sylvester","year":"2004","journal-title":"J Urol"},{"key":"10.1016\/j.acuroe.2026.501904_bib0050","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/j.euf.2018.11.005","article-title":"Risk stratification tools and prognostic models in non-muscle-invasive bladder cancer: a critical assessment from the European association of urology non-muscle-invasive bladder cancer guidelines panel","volume":"6","author":"Soukup","year":"2020","journal-title":"Eur Urol Focus"},{"key":"10.1016\/j.acuroe.2026.501904_bib0055","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1016\/j.eururo.2005.12.031","article-title":"Predicting recurrence and progression in individual patients with stage Ta T1 bladder cancer using EORTC risk tables: a combined analysis of 2596 patients from seven EORTC trials","volume":"49","author":"Sylvester","year":"2006","journal-title":"Eur Urol"},{"key":"10.1016\/j.acuroe.2026.501904_bib0060","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1016\/j.euf.2017.09.002","article-title":"Discrepancy between European association of urology guidelines and daily practice in the management of non-muscle-invasive bladder cancer: results of a European survey","volume":"5","author":"Hendricksen","year":"2019","journal-title":"Eur Urol Focus"},{"key":"10.1016\/j.acuroe.2026.501904_bib0065","doi-asserted-by":"crossref","DOI":"10.5812\/numonthly.29967","article-title":"Improving compliance with a single post-operative dose of intravesical chemotherapy after transurethral resection of bladder tumour","volume":"8","author":"Stroman","year":"2016","journal-title":"Nephrourol Mon"},{"key":"10.1016\/j.acuroe.2026.501904_bib0070","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1590\/S1677-5538.IBJU.2015.0122","article-title":"Are we following the guidelines on non-muscle invasive bladder cancer?","volume":"42","author":"Reis","year":"2016","journal-title":"Int Braz J Urol"},{"key":"10.1016\/j.acuroe.2026.501904_bib0075","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/j.urpr.2014.12.008","article-title":"Process improvements positively impact the use of intravesical mitomycin C after transurethral resection of nonmuscle invasive bladder cancer in a large","volume":"2","author":"Cusano","year":"2015","journal-title":"Urol Pract"},{"key":"10.1016\/j.acuroe.2026.501904_bib0080","series-title":"EVIDENCIO","article-title":"EORTC risk tables: Predicting recurrence and progression in stage Ta T1 bladder cancer patients","year":"2018"},{"key":"10.1016\/j.acuroe.2026.501904_bib0085","doi-asserted-by":"crossref","first-page":"2051","DOI":"10.1007\/s00345-018-02624-3","article-title":"Impact of intravesical therapy for non-muscle invasive bladder cancer on the accuracy of urine cytology","volume":"37","author":"Gupta","year":"2019","journal-title":"World J Urol"},{"key":"10.1016\/j.acuroe.2026.501904_bib0090","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/j.eururo.2004.05.003","article-title":"One immediate postoperative instillation of chemotherapy in low risk Ta, T1 bladder cancer patients. Is it always safe?","volume":"46","author":"Oddens","year":"2004","journal-title":"Eur Urol"},{"key":"10.1016\/j.acuroe.2026.501904_bib0095","doi-asserted-by":"crossref","first-page":"E34","DOI":"10.1111\/bju.12340","article-title":"Destruction of the bladder by single dose Mitomycin C for low-stage transitional cell carcinoma (TCC)\u2014avoidance, recognition, management and consent","volume":"113","author":"Elmamoun","year":"2014","journal-title":"BJU Int"},{"key":"10.1016\/j.acuroe.2026.501904_bib0100","doi-asserted-by":"crossref","first-page":"2004","DOI":"10.1016\/S0022-5347(06)00264-3","article-title":"Complications of intravesical therapy for urothelial cancer of the bladder","volume":"175","author":"Koya","year":"2006","journal-title":"J Urol"},{"key":"10.1016\/j.acuroe.2026.501904_bib0105","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1097\/JU.0000000000003846","article-title":"Diagnosis and treatment of non-muscle invasive bladder cancer: AUA\/SUO guideline: 2024 amendment","volume":"211","author":"Holzbeierlein","year":"2024","journal-title":"J Urol"}],"container-title":["Actas Urol\u00f3gicas Espa\u00f1olas (English Edition)"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2173578626000107?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2173578626000107?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T15:49:25Z","timestamp":1780588165000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2173578626000107"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":21,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["S2173578626000107"],"URL":"https:\/\/doi.org\/10.1016\/j.acuroe.2026.501904","relation":{},"ISSN":["2173-5786"],"issn-type":[{"value":"2173-5786","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The use of presurgical urine cytology improves patient selection for a single instillation of MMC","name":"articletitle","label":"Article Title"},{"value":"Actas Urol\u00f3gicas Espa\u00f1olas (English Edition)","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.acuroe.2026.501904","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.acuro.2025.501904","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 AEU. Published by Elsevier Espa\u00f1a, S.L.U. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"501904"}}